www.fdanews.com/articles/206196-united-ppe-americas-crispr-sars-cov-2-test-kit-gets-ce-mark
United PPE America’s CRISPR SARS-CoV-2 Test Kit Gets CE Mark
January 18, 2022
United PPE America has received a CE mark certification for its CRISPR SARS-CoV-2 test kit which uses genetic engineering technology licensed from Cambridge, Mass.-based Sherlock Biosciences.
The test has specificity and sensitivity on par with conventional polymerase chain reaction (PCR) testing methods and a turnaround time from sample to read-out of less than one hour, according to United PPE.
Sherlock Biosciences CEO, Bryan Dechairo, said the company’s CRISPR diagnostic technology can enable increased access to diagnostics globally.